Immucor
AcquiredWerfen | Leading Provider Of Transfusion & Transplantation Diagnostic Products Worldwide
Norcross, United States · Founded 1982 · $2.0B raised
- Headquarters
- Norcross, Georgia
- Employees
- 5001–10000
- Founded
- 1982
- Business Model
- B2B
- Total Funding
- $2.0B
- Acquisition Date
- Mar 2023
About
Global leader in transfusion and transplantation diagnostics providing products and solutions to ensure donor-recipient compatibility. Serves hospitals, clinical laboratories, and donor centers worldwide with serology, molecular products, and coagulation diagnostics.
Summary
Immucor is a Biotech company based in Norcross, United States, founded in 1982. It has raised $2.0B in total. Investors include We Venture Capital and TPG (Growth/Rise).
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company
